Navigation Links
Implantable devices to be powered by organosilicon compounds in the future

Medical technology has advanced so much to the extent of replacing lost organs or improving function of existing ones using artificial implants. These implantable devices are becoming commonplace today by serving as a good // alternative to the conventional treatment.

Such effective utilization would not have been possible without the availability of lithium batteries that supply power, thereby ensuring functionality of these tiny, yet useful devices. Designed to be extraordinarily reliable and work continuously for years, the batteries that power implantables are indispensable in everything from pacemakers to the electronic stimulators that help restore function in the brains of Parkinson's patients.

However, lithium batteries don't last forever and new surgery to maintain many devices seeded into the body is required. It is both a physical and financial strain for the patient. In an attempt to ensure superior performance, scientists are now working on silicon-based compounds that are used in the treatment of nervous and other disorders. The unique rechargeable ability of the new generation battery confers twice as longer lifetime than the ones currently used.

This offers a new ray of hope in medical treatment as these new generation electrical devices could be used to stimulate the nervous system, treat incontinence and overcome muscular impairment.

Central to that ability and vision, is emerging a new lithium battery technology, capable of making batteries smaller, last longer and, soon, accept a charge from outside the body without the need for surgery. "It turns out the organosilicon compounds (compounds made of silicon and other natural materials) are really good for improving lithium battery technology," says West, one instrumental behind this significant development. The new battery technology powers a "microstimulater" not much larger than a pencil lead and can be injected near target nerves to help overcome t he faulty nervous system wiring at the heart of Parkinson's, epilepsy and incontinence.

They're very flexible, stable, nonflammable, non-toxic and do not pose a threat to the environment, according to the researchers. The average expected life span of these batteries is expected to be over 12 years. Furthermore, it makes use of Silicon, one of the Earth's most abundant elements.

In addition to implantable devices for medicine, lithium batteries are used in scores of applications, from spacecraft to iPods. We will have to watch and wait for some time before the power of these batteries can be exploited to the maximum.
'"/>




Related medicine news :

1. Implantable Contact Lens Found Safe and Effective
2. New Implantable Device That Can Keep The Heart Ticking
3. Making MRIs Safe for Patients With Implantable Heart Devices
4. Combination therapy for patients treated with Implantable Cardioverter Defibrillator
5. New Implantable Cardioverter Defibrillators to avoid unnecessary shocks
6. First Implantable artificial heart gets FDA’s approva
7. Futuristic devices are here to take care of dental problems
8. Cheap Indian devices sought to treat sleep disorder
9. Bionic muscles developed by scientists powered by alcohol and hydrogen
10. Patients Empowered to Force for Better Services
11. China Introduces Solar-powered Baths
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/19/2017)... ... February 19, 2017 , ... "At your fingertips" electronic access ... and the Delaware Health Information Network (DHIN) have partnered to improve connectivity of ... health information exchange, DHIN stores and shares real-time health data for more than ...
(Date:2/18/2017)... ... February 17, 2017 , ... Butler Mobility invited Ken Matthews ... and other Butler products. Ken was impressed with the safety and reliability of ... the product on his show. This endorsement by Ken Matthews can be heard ...
(Date:2/18/2017)... (PRWEB) , ... February 18, 2017 , ... ... today provides the latest information and contact points to easily connect elderly veterans ... care, assisted living, and elder-care funding. It also conveys material on this year's ...
(Date:2/17/2017)... ... 17, 2017 , ... Wells Pharmacy Network offers physicians WellsPx3, ... and non-controlled substances plus the ability to manage orders on their desktop or ... accept electronic prescriptions, according to the Office of the National Coordinator of Health ...
(Date:2/17/2017)... ... February 17, 2017 , ... Corrective Action ... Letter, **An FDAnews Webinar**, Feb. 23, 2017 — 1:30 p.m. – 3:00 p.m. ... action (CA) and preventive action (PA)? , The methods share techniques and tools ...
Breaking Medicine News(10 mins):
(Date:2/17/2017)... Cryoablation, Electrical, Endometrial Hydrothermal, Laser/Light, Microwave, Radiofrequency, Ultrasound, Cardiovascular, Gynaecology, Musculoskeletal, ... to grow at a CAGR of 9.4% from 2017-2022 and CAGR ... a CAGR of 9.5% from 2017 to 2027. The market is ... ... you Read on to discover how you can exploit the ...
(Date:2/17/2017)... , Feb. 17, 2017 Theravance Biopharma, ... or the "Company") today announced the presentation of ... and orally administered pan-Janus kinase (JAK) inhibitor designed ... Congress of the European Crohn,s and Colitis ... reported further data from its completed Phase 1 ...
(Date:2/17/2017)...   Risperdal lawsuits involving gynecomastia (male breast growth) ... of the atypical antipsychotic medication continue to move forward ... Common Pleas, where the state,s Risperdal docket has been ... notice posted on the Court,s website , the ... 9, 2017 at 11:00 a.m. (In Re: Risperdal Litigation, ...
Breaking Medicine Technology: